Skip to main content
. 2017 Jun 26;8(9):1925–1936. doi: 10.1021/acschemneuro.7b00086

Figure 2.

Figure 2

Whole brain time–activity curves of [18F]1 and [18F]2 in Wistar rats at (●) baseline and (■) after treatment with tariquidar (15 mg/kg).